| Issue | Title | |
| Vol 21, No 1 (2014) | Early prediction of treatment response in advanced gliomas with 18F-DOPA positron-emission tomography | Abstract PDF HTML |
| N. Dowson, P. Thomas, M. Fay, R.L. Jeffree, Y. Gal, P. Bourgeat, J. Smith, C. Winter, A. Coulthard, O. Salvado, S. Crozier, S. Rose | ||
| Vol 18, No 5 (2011) | Early-onset breast cancer: what do we know about the risk factors? | Details PDF HTML |
| S. A. Narod | ||
| Vol 23, No 1 (2016) | Eastern Canadian Colorectal Cancer Consensus Conference 2013: emerging therapies in the treatment of pancreatic, rectal, and colorectal cancers | Abstract PDF HTML |
| T. Di Valentin, T. Asmis, J. Asselah, F. Aubin, N. Aucoin, S. Berry, J. Biagi, C.M. Booth, R. Burkes, N. Coburn, B. Colwell, C. Cripps, L.A. Dawson, M. Dorreen, D. Frechette, R. Goel, S. Gray, N. Hammad, D. Jonker, P. Kavan, J. Maroun, S. Nanji, D. Roberge, B. Samson, M. Seal, W. Shabana, M. Simunovic, S. Snow, M. Tehfe, M. Thirlwell, E. Tsvetkova, M. Vickers, T. Vuong, R. Goodwin | ||
| Vol 25, No 4 (2018) | Eastern Canadian Colorectal Cancer Consensus Conference 2017 | Abstract PDF HTML |
| S.F. McGee, W. AlGhareeb, C.H. Ahmad, D. Armstrong, S. Babak, S. Berry, J. Biagi, C. Booth, D. Bossé, P. Champion, B. Colwell, N. Finn, R. Goel, S. Gray, J. Green, M. Harb, A. Hyde, A. Jeyakumar, D. Jonker, S. Kanagaratnam, P. Kavan, A. MacMillan, A. Muinuddin, N. Patil, G. Porter, E. Powell, R. Ramjeesingh, M. Raza, S. Rorke, M. Seal, F. Servidio-Italiano, J. Siddiqui, J. Simms, L. Smithson, S. Snow, E. St-Hilaire, T. Stuckless, A. Tate, M. Tehfe, M. Thirlwell, E. Tsvetkova, M. Valdes, M. Vickers, K. Virik, S. Welch, C. Marginean, T. Asmis | ||
| Vol 19, No 3 (2012) | Eastern Canadian Colorectal Cancer Consensus Conference: application of new modalities of staging and treatment of gastrointestinal cancers | Abstract PDF HTML |
| T. Di Valentin, Y. Alam, A. Ali Alsharm, S. Arif, F. Aubin, J. Biagi, C.M. Booth, S. Bourque, R. Burkes, P. Champion, B. Colwell, C. Cripps, M. Dallaire, M. Dorreen, N. Finn, D. Frechette, S. Gallinger, J. Gapski, C. Giacomantonio, S. Gill, R. Goel, R. Goodwin, L. Grimard, A. Grothey, N. Hammad, D. Hedley, K. Jhaveri, D. Jonker, Y. Ko, M. L’Espérance, J. Maroun, H. Ostic, N. Perrin, M. Rother, E. St-Hilaire, M. Tehfe, M. Thirlwell, S. Welch, N. Yarom, T. Asmis | ||
| Vol 17, No 3 (2010) | Eastern Canadian Colorectal Cancer Consensus Conference: setting the limits of resectable disease | Abstract PDF |
| M. Vickers, B. Samson, B. Colwell, C. Cripps, D. Jalink, S. El-Sayed, E. Chen, G. Porter, R. Goel, J. Villeneuve, S. Sundaresan, J. Asselah, J. Biagi, D. Jonker, L. Dawson, R. Letourneau, M. Rother, J. Maroun, M. Thirlwell, M. Hussein, M. Tehfe, N. Perrin, N. Michaud, N. Hammad, P. Champion, R. Rajan, R. Burkes, S. Barrette, S. Welch, N. Yarom, T. Asmis | ||
| Vol 20, No 5 (2013) | Eastern Canadian Colorectal Cancer Consensus Conference: standards of care for the treatment of patients with rectal, pancreatic, and gastrointestinal stromal tumours and pancreatic neuroendocrine tumours | Abstract PDF HTML |
| T. Di Valentin, J. Biagi, S. Bourque, R. Butt, P. Champion, V. Chaput, B. Colwell, C. Cripps, M. Dorreen, S. Edwards, C. Falkson, D. Frechette, S. Gill, R. Goel, D. Grant, N. Hammad, A. Jeyakumar, M. L’Espérance, C. Marginean, J. Maroun, M. Nantais, N. Perrin, C. Quinton, M. Rother, B. Samson, J. Siddiqui, S. Singh, S. Snow, E. St-Hilaire, M. Tehfe, M. Thirlwell, S. Welch, L. Williams, F. Wright, R. Goodwin | ||
| Vol 22, No 4 (2015) | Eastern Canadian Gastrointestinal Cancer Consensus Conference 2014 | Abstract PDF HTML |
| E. Tsvetkova, S. Sud, N. Aucoin, J. Biagi, R. Burkes, B. Samson, S. Brule, C. Cripps, B. Colwell, C. Falkson, M. Dorreen, R. Goel, F. Halwani, J. Maroun, N. Michaud, M. Tehfe, M. Thirlwell, M. Vickers, T. Asmis | ||
| Vol 23, No 6 (2016) | Eastern Canadian Gastrointestinal Cancer Consensus Conference 2016 | Abstract PDF HTML |
| D. Bossé, T. Ng, C. Ahmad, A. Alfakeeh, I. Alruzug, J. Biagi, J. Brierley, P. Chaudhury, S. Cleary, B. Colwell, C. Cripps, L.A. Dawson, M. Dorreen, E. Ferland, P. Galiatsatos, S. Girard, S. Gray, F. Halwani, N. Kopek, A. Mahmud, G. Martel, L. Robillard, B. Samson, M. Seal, J. Siddiqui, L. Sideris, S. Snow, M. Thirwell, M. Vickers, R. Goodwin, R. Goel, T. Hsu, E. Tsvetkova, B. Ward, T. Asmis | ||
| Vol 26, No 5 (2019) | Eastern Canadian Gastrointestinal Cancer Consensus Conference 2018 | Abstract HTML PDF |
| A.J. Hyde, R. Nassabein, A. AlShareef, D. Armstrong, S. Babak, S. Berry, D. Bossé, E. Chen, B. Colwell, C. Essery, R. Goel, R. Goodwin, S. Gray, N. Hammad, A. Jeyakumar, D. Jonker, P. Karanicolas, N. Lamond, R. Letourneau, J. Michael, N. Patil, E. Powell, R. Ramjeesingh, W. Saliba, R. Singh, S. Snow, T. Stuckless, S. Tadros, M. Tehfé, M. Thana, M. Thirlwell, M. Vickers, K. Virik, S. Welch, T. Asmis | ||
| Vol 24, No 1 (2017) | Economic evaluation of brentuximab vedotin for persistent Hodgkin lymphoma | Abstract PDF HTML |
| V. Babashov, M.A. Begen, J. Mangel, G.S. Zaric | ||
| Vol 22, No 2 (2015) | Economic evaluation of hormonal therapies for postmenopausal women with estrogen receptor–positive early breast cancer in Canada | Abstract PDF HTML |
| S. Djalalov, J. Beca, E. Amir, M. Krahn, M.E. Trudeau, J.S. Hoch | ||
| Vol 14, No 2 (2007) | Editorial | Details PDF |
| Mike McLean | ||
| Vol 14, No 3 (2007) | Editorial | Details PDF |
| Mike McLean | ||
| Vol 14, No 4 (2007) | Editorial | Details PDF |
| Mike McLean | ||
| Going Beyond Efficacy | Editorial | Details PDF |
| Sunil Verma | ||
| Vol 15, No 3 (2008) | Editorial | Abstract PDF |
| Phil Gold | ||
| Vol 15, No 5 (2008) | EDITORIAL | Abstract PDF |
| Richard J. Ablin | ||
| Vol 15, No 6 (2008) | Editorial | Abstract PDF |
| Mike McLean | ||
| Vol 16, No 1 (2009) | Editorial | Abstract PDF |
| Mike McLean | ||
| Vol 16, No 2 (2009) | Editorial | Abstract PDF |
| Mike McLean | ||
| Vol 16, No 4 (2009) | Editorial | Abstract PDF |
| Mike McLean | ||
| Vol 18, No 2 (2011) | Editorial | Details PDF HTML |
| M. McLean | ||
| Vol 18, No 3 (2011) | Editorial | Details PDF HTML |
| Mike McLean | ||
| Vol 15, No 2 (2008) | editorial 2_08 | Abstract PDF |
| Mike McLean | ||
| Vol 13, No 5 (2006) | Editorial 5/06 | Details PDF |
| Michael McLean | ||
| Vol 14, No 5 (2007) | Editorial 5/07 | Details PDF |
| Mike McLean | ||
| Vol 14, No 6 (2007) | Editorial 6/2007 | Details PDF |
| Mike McLean | ||
| Vol 15, No 1 (2008) | Editorial for 1/2008 | Details PDF |
| Mike McLean | ||
| Vol 13, No 4 (2006) | Editorial4_06 | Details PDF |
| Michael McLean | ||
| Vol 15, No 4 (2008) | Editorial: Integrative Oncology and an Integrative Cancer Journal | Abstract PDF |
| Stephen Sagar | ||
| Vol 13, No 3 (2006) | Editorial: Volume 13, Number 3 | Details PDF |
| Michael McLean | ||
| Vol 13, No 6 (2006) | Editorial: Volume 13, Number 6 | Details PDF |
| Michael McLean | ||
| Vol 20, No 1 (2013) | Effect of cancer on ovarian function in patients undergoing in vitro fertilization for fertility preservation: a reappraisal | Details PDF HTML |
| I. Levin, B. Almog | ||
| Vol 23, No 6 (2016) | Effect of chemotherapy on health-related quality of life among early-stage ovarian cancer survivors: a study from the population-based PROFILES registry | Abstract PDF HTML |
| C.S. Bhugwandass, J.M.A. Pijnenborg, B. Pijlman, N.P.M. Ezendam | ||
| Vol 25, No 1 (2018) | Effect of early palliative care on quality of life in patients with non-small-cell lung cancer | Abstract PDF HTML |
| H. Zhuang, Y. Ma, L. Wang, H. Zhang | ||
| Vol 19, No 3 (2012) | Effect of exercise in reducing breast and chest-wall pain in patients with breast cancer: a pilot study | Abstract PDF HTML |
| P. Wong, T. Muanza, T. Hijal, L. Masse, S. Pillay, M. Chasen, I. Lowensteyn, M. Gold, S. Grover | ||
| Vol 24, No 3 (2017) | Effect of non-alcoholic liver disease on recurrence rate and liver regeneration after liver resection for colorectal liver metastases | Abstract PDF HTML |
| N.W. Molla, M.M. Hassanain, Z. Fadel, L.M. Boucher, A. Madkhali, R.M. Altahan, E.A. Alrijraji, E.B. Simoneau, H. Alamri, A. Salman, Z. Gao, P.P. Metrakos | ||
| Vol 26, No 3 (2019) | Effect of obesity, dyslipidemia, and diabetes on trastuzumab-related cardiotoxicity in breast cancer | Abstract PDF HTML Supplemental Material |
| P. Kosalka, C. Johnson, M. Turek, J. Sulpher, A. Law, J. Botros, S. Dent, O. Aseyev | ||
| Vol 21, No 3 (2014) | Effect of preoperative chemoradiotherapy on outcome of patients with locally advanced esophagogastric junction adenocarcinoma—a pilot study | Abstract PDF HTML |
| M. Orditura, G. Galizia, N. Di Martino, E. Ancona, C. Castoro, R. Pacelli, F. Morgillo, S. Rossetti, V. Gambardella, A. Farella, M.M. Laterza, A. Ruol, A. Fabozzi, V. Napolitano, F. Iovino, E. Lieto, L. Fei, A. Renda, F. Ciardiello, F. De Vita | ||
| Vol 26, No 3 (2019) | Effectiveness of first-line treatments in metastatic squamous non-small-cell lung cancer | Abstract PDF HTML |
| B. P. Levy, J. E. Signorovitch, H. Yang, O. Patterson-Lomba, C. Q. Xiang, M. Parisi | ||
| Vol 21, No 2 (2014) | Effects of dna-dependent protein kinase inhibition by NU7026 on dna repair and cell survival in irradiated gastric cancer cell line N87 | Abstract PDF HTML |
| M.T. Niazi, G. Mok, M. Heravi, L. Lee, T. Vuong, R. Aloyz, L. Panasci, T. Muanza | ||
| Vol 26, No 1 (2019) | Effects of magnanimous therapy on coping, adjustment, and living function in advanced lung cancer | Abstract PDF HTML |
| X. Huang, A. Yan, Q. Liu, L. Wu | ||
| Vol 19, No 4 (2012) | Effects of radiation and total androgen blockade on serum hemoglobin, testosterone, and erythropoietin in patients with localized prostate cancer | Abstract PDF HTML |
| M. Golfam, R. Samant, L. Eapen, S. Malone | ||
| Vol 24, No 5 (2017) | Effects of the community-based Wellspring Cancer Exercise Program on functional and psychosocial outcomes in cancer survivors | Abstract PDF HTML |
| D. Santa Mina, D. Au, J. Brunet, J. Jones, G. Tomlinson, N. Taback, D. Field, A. Berlingeri, H. Bradley, D. Howell | ||
| Vol 23, No 1 (2016) | Effects of warm acupuncture on breast cancer–related chronic lymphedema: a randomized controlled trial | Abstract PDF HTML |
| C. Yao, Y. Xu, L. Chen, H. Jiang, C.S. Ki, J.S. Byun, W. Bian | ||
| Vol 26, No 1 (2019) | Efficacy and safety of combined androgen blockade with antiandrogen for advanced prostate cancer | Abstract PDF HTML |
| Y. Yang, R. Chen, T. Sun, L. Zhao, F. Liu, S. Ren, H. Wang, X. Lu, X. Gao, C. Xu, Y. Sun | ||
| Vol 20, No 4 (2013) | Efficacy and tolerability of toremifene and tamoxifen therapy in premenopausal patients with operable breast cancer: a retrospective analysis | Abstract PDF HTML |
| T. Qin, Z.Y. Yuan, R.J. Peng, Y.D. Zeng, Y.X. Shi, X.Y. Teng, D.G. Liu, B. Bai, S.S. Wang | ||
| Vol 24, No 3 (2017) | Efficacy of metronomic vinorelbine in elderly patients with advanced non-small-cell lung cancer and poor performance status | Abstract PDF HTML |
| C. Bilir, S. Durak, B. Kızılkaya, I. Hacıbekiroglu, E. Nayır, H. Engin | ||
| Vol 26, No 1 (2019) | Efficacy of second-line chemotherapy after a first-line triplet in patients with metastatic colorectal cancer | Abstract PDF HTML |
| S. Bazarbashi, A. M. Hakoun, A. M. Gad, M. A. Elshenawy, A. Aljubran, A. Alzahrani, A. Eldali | ||
| Vol 17 (2010): Optimal management of metastatic colorectal cancer with the anti-EGFR monoclonal antibodies | Efficacy of the monoclonal antibody EGFR inhibitors for the treatment of metastatic colorectal cancer | Abstract PDF |
| M. Fakih, R. Wong | ||
| Vol 16, No 5 (2009) | Efficacy of third-line therapy using bevacizumab in a patient with metastatic colorectal cancer | Details PDF |
| J. Gaulin, R. Kotb, E. Turcotte, G. Bérard, G. Schmutz, B. Sawan, P. Beauregard | ||
| Vol 17, No 1 (2010) | EGFR overexpression in squamous cell carcinoma of the penis | Abstract PDF |
| N. Lavens, R. Gupta, L.A. Wood | ||
| Vol 19, No 1 (2012) | EGFR tyrosine kinase inhibitors in lung cancer: make no assumptions | Abstract PDF HTML |
| B. Melosky | ||
| Vol 19, No 2 (2012) | EGFR tyrosine kinase mutation testing in the treatment of non-small-cell lung cancer | Abstract PDF HTML |
| S. Kamel-Reid, G. Chong, D.N. Ionescu, A.M. Magliocco, A. Spatz, M. Tsao, X. Weng, S. Young, T. Zhang, D. Soulieres | ||
| Vol 25, No 5 (2018) | Elective nodal irradiation or involved-field irradiation in definitive chemoradiotherapy for esophageal squamous cell cancer: a retrospective analysis in clinical N0 patients | Abstract PDF HTML |
| Y. Sun, X. L.. Zhang, Q. F. Mao, Y. H. Liu, L. Kong, M.H. Li | ||
| Vol 16, No 2 (2009) | Electrochemotherapy of tumors | Abstract PDF |
| Marko Snoj | ||
| Vol 18, No 1 (2011) | E-Manuscript Article Summaries | Details PDF HTML |
| Various Authors | ||
| Vol 18, No 2 (2011) | E-Manuscript Article Summaries | Details PDF HTML |
| Various Authors | ||
| Vol 18, No 3 (2011) | E-Manuscript Article Summaries | Details PDF HTML |
| Various Authors | ||
| Vol 18, No 4 (2011) | E-manuscript Article Summaries | Details PDF HTML |
| Amanda Shand | ||
| Vol 18, No 5 (2011) | E-manuscript Article Summaries | Details PDF HTML |
| Various Authors | ||
| Vol 18, No 6 (2011) | E-manuscript article summaries | Abstract PDF HTML |
| Current Oncology | ||
| Vol 19, No 1 (2012) | E-manuscript Article Summaries | Abstract PDF HTML |
| Multiple Authors | ||
| Vol 19, No 2 (2012) | E-manuscript article summaries | Abstract PDF HTML |
| Various Authors | ||
| Vol 26, No 4 (2019) | Emerging therapies for the treatment of relapsed or refractory diffuse large B cell lymphoma | Abstract PDF HTML |
| P. Skrabek, S. Assouline, A. Christofides, D. MacDonald, A. Prica, R. Sangha, B. A. Matthews, L. H. Sehn | ||
| Vol 23, No 6 (2016) | Emerging therapies for the treatment of relapsed or refractory follicular lymphoma | Abstract PDF HTML |
| D. MacDonald, A. Prica, S. Assouline, A. Christofides, T. Lawrence, L.H. Sehn | ||
| Vol 18, No 4 (2011) | Emerging trends in the treatment of triple-negative breast cancer in Canada: a survey | Abstract PDF HTML |
| S. Verma, L. Provencher, R. Dent | ||
| Vol 26, No 4 (2019) | Employment outcomes for recent Canadian radiation oncology graduates | Abstract PDF HTML |
| S. K. Loewen, R. Halperin, G. Perry, M. Mckenzie, E. Vigneault, T. Stuckless, M. Brundage | ||
| Vol 22, No 6 (2015) | Enablers and barriers in delivery of a cancer exercise program: the Canadian experience | Abstract PDF HTML |
| D. Santa Mina, A. Petrella, K.L. Currie, K. Bietola, S.M.H. Alibhai, J. Trachtenberg, P. Ritvo, A.G. Matthew | ||
| Vol 17, No 6 (2010) | Encouraging data out of the 2010 Congress of the European Society for Medical Oncology with respect to non-small-cell lung cancer | Details PDF |
| V. Hirsh | ||
| Vol 25, No 4 (2018) | Endocrine therapy for breast cancer in the primary care setting | Abstract PDF HTML |
| A. Awan, A. Esfahani | ||
| Vol 17, No 5 (2010) | Endocrine therapy for male breast cancer: rates of toxicity and adherence | Abstract PDF |
| H. Visram, F. Kanji, S. F. Dent | ||
| Vol 20, No 1 (2013) | Endocrine therapy for postmenopausal women with hormone receptor–positive her2–negative advanced breast cancer after progression or recurrence on nonsteroidal aromatase inhibitor therapy: a Canadian consensus statement | Abstract PDF HTML |
| K.I. Pritchard, K.A. Gelmon, D. Rayson, L. Provencher, Marc Webster, D. McLeod, S. Verma | ||
| Vol 17, No 6 (2010) | Endometrioid ovarian carcinoma benefits from aromatase inhibitors: case report and literature review | Abstract PDF |
| Y. Pan, M.S. Kao | ||
| Vol 25, No 4 (2018) | Engaging cancer patients in clinical practice guideline development: a pilot study | Abstract PDF Supplemental Material HTML |
| M.C. Brouwers, M. Vukmirovic, K. Spithoff, C. Zwaal, S. McNair, N. Peek | ||
| Vol 22, No 4 (2015) | Enhancing access to cancer care for the Inuit | Abstract PDF HTML |
| P. Doering, C. DeGrasse | ||
| Vol 26, No 2 (2019) | Epidermal growth factor receptor inhibitor–induced hypomagnesemia: a survey of practice patterns among Canadian gastrointestinal medical oncologists | Abstract PDF HTML |
| T. Thangarasa, J. Gotfrit, R. A. Goodwin, P. A. Tang, M. Clemons, A. Imbulgoda, M. M. Vickers | ||
| Vol 17, No 3 (2010) | Epidermal growth factor receptor targeted therapy in stage III and IV head and neck cancer | Abstract PDF |
| C. Cripps, E. Winquist, M. C. Devries, D. Stys-Norman, R. Gilbert | ||
| Vol 25, No 4 (2018) | Erratum: Cost-effectiveness of everolimus for the treatment of advanced neuroendocrine tumours of gastrointestinal or lung origin in Canada | Abstract PDF HTML |
| A. Chua, A. Perrin, J.F. Ricci, M.P. Neary, M. Thabane | ||
| Vol 26, No 6 (2019) | Erratum: Current and emerging biomarkers in metastatic colorectal cancer | Abstract PDF HTML |
| M.K.C. Lee, Jonathan M. Loree | ||
| Vol 19, No 3 (2012) | Erratum: Legalizing euthanasia or assisted suicide: the illusion of safeguards and controls | Details PDF HTML |
| J. Pereira | ||
| Vol 21, No 6 (2014) | Erratum: Salpingectomy to prevent ovarian cancer | Abstract PDF HTML |
| S.A. Narod | ||
| Vol 22, No 2 (2015) | Erratum: Tumour inflammatory response: adding fuel to the fire? | Abstract PDF HTML |
| M. Valdes, M.R. Chasen | ||
| Going Beyond Efficacy | Erythropoiesis Stimulating Agents: Benefits/Risks in Supportive Care of Cancer | Abstract PDF |
| Barbara L. Melosky | ||
| Vol 22, No 2 (2015) | Establishing a clinic-based pancreatic cancer and periampullary tumour research registry in Quebec | Abstract PDF HTML |
| A.L. Smith, C. Bascuñana, A. Hall, A. Salman, A.Z. Andrei, A. Volenik, H. Rothenmund, D. Ferland, D. Lamoussenery, A.S. Kamath, R. Amre, D. Caglar, Z.H. Gao, D.G. Haegert, Y. Kanber, R.P. Michel, G. Omeroglu-Altinel, J. Asselah, N. Bouganim, P. Kavan, G. Arena, J. Barkun, P. Chaudhury, S. Gallinger, W.D. Foulkes, A. Omeruglu, P. Metrakos, G. Zogopoulos | ||
| Vol 18, No 5 (2011) | Establishing a multicentre clinical research network: lessons learned | Abstract PDF HTML |
| N. A. Hagen, C. R. Stiles, P. D. Biondo, G. G. Cummings, R. L. Fainsinger, D. E. Moulin, J. L. Pereira, R. Spice | ||
| Vol 26, No 2 (2019) | Establishing funding rates for colonoscopy and gastroscopy procedures in Ontario | Abstract PDF HTML Supplemental Material |
| J. Monakova, J. Wong, I. Blais, A. Langan, N. Ratansi, D. Morgan, N. N. Baxter | ||
| Vol 26, No 2 (2019) | Estimating Health Care Costs of Non-Melanoma Skin Cancer in Saskatchewan using Physician Billing Data | Abstract PDF HTML |
| D. A. Tran, A. C. Coronado, S. Sarker, R. Alvi | ||
| Vol 23, No 3 (2016) | Estimating the costs of intensity-modulated and 3-dimensional conformal radiotherapy in Ontario | Abstract PDF HTML |
| J.H.E Yong, T. McGowan, R. Redmond-Misner, J. Beca, P. Warde, E. Gutierrez, J.S. Hoch | ||
| Vol 17, No 2 (2010) | Estimating the national wage loss from cancer in Canada | Abstract PDF |
| R. B. Hopkins, R. Goeree, C. J. Longo | ||
| Vol 23 (2016): Original Cancer Costing Research Using Canadian Data | Estimation of drug cost avoidance and pathology cost avoidance through participation in NCIC Clinical Trials Group phase III clinical trials in Canada | Abstract PDF HTML |
| P.A. Tang, A.E. Hay, C.J. O’Callaghan, N. Mittmann, C.R. Chambers, J.L. Pater, N.B. Leighl | ||
| Vol 13, No 2 (2006) | ETHICAL GUIDEPOSTS TO CLINICAL TRIALS IN ONCOLOGY | Details PDF |
| Mark Bernstein | ||
| Vol 22, No 2 (2015) | Ethnicity and breast cancer stage at diagnosis: an issue of health equity | Abstract PDF HTML |
| A.K. Lofters | ||
| Vol 19, No 5 (2012) | Evaluating the efficacy of current clinical practice of adjuvant chemotherapy in postmenopausal women with early-stage, estrogen or progesterone receptor–positive, one-to-three positive axillary lymph node, breast cancer | Abstract PDF HTML |
| M.B. Hannouf, M. Brackstone, B. Xie, G.S. Zaric | ||
| Vol 17, No 4 (2010) | Evaluating the impact on quality of life of chemoradiation in gastric cancer | Abstract PDF |
| Z. Kassam, H. Mackay, C.A. Buckley, S. Fung, M. Pintilie, J. Kim, J. Ringash | ||
| Vol 20, No 1 (2013) | Evaluation of CancerChatCanada: a program of online support for Canadians affected by cancer | Abstract PDF HTML |
| J. Stephen, A. Rojubally, K. MacGregor, D. McLeod, M. Speca, J. Taylor-Brown, K. Fergus, K. Collie, J. Turner, S. Sellick, G. Mackenzie | ||
| Vol 17, No 2 (2010) | Evaluation of six risk factors for the development of bacteremia in children with cancer and febrile neutropenia | Abstract PDF |
| J. E. Corral, J. Quezada, E. J. Asturias | ||
| Vol 25, No 5 (2018) | Evaluation of subcutaneous rituximab administration on Canadian systemic therapy suites | Abstract PDF HTML |
| D. A. Stewart, J.S. Boudreault, B. Maturi, D. Boras, R. Foley | ||
| Vol 20, No 2 (2013) | Evaluation of the clinical benefits of nanoparticle albumin-bound paclitaxel in women with metastatic breast cancer in British Columbia | Abstract PDF HTML |
| A.E. Lohmann, C.H. Speers, S.K. Chia | ||
| 501 - 600 of 1709 Items | << < 1 2 3 4 5 6 7 8 9 10 > >> | |
User
Current Oncology is published by:
Endorsed publication of the Canadian Association of Medical Oncologists (CAMO)
